疏肝止痛方治疗气滞血瘀型原发性痛经的临床观察论文

《疏肝止痛方治疗气滞血瘀型原发性痛经的临床观察论文》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、ClinicalResearchonTreatingtheQiandBloodstasisPrimaryDysmenorrheawiththeShuGanZhiTongDecoctionSpeciality：GynecologyofTCMAuthor：ZhuwenyanTutor：ProfessorLvMeiAbstractObjective:ToobservetheclinicaleffectionoftreatingthestagnationofqiandbloodstasisPrimaryDysmenorrheawithth

2、eShuGanZhiTong(SGZT)Decoctionandexplorethefunctionmechanismofit.Methods:78patientsweredividedintothreegroupsrandomly:thetreatmentgroupⅠ(26cases,treatedwithSGZTforthreemonths,sevendaysbytheformerfromtheoral),thetreatmentgroupⅡ(26cases,treatedwithSGZTforthreemonths,four

3、teendaysbytheformerfromtheoral)andthecontrolgroup(26cases,treatedwithDanErFuKangDFEforthreemonths).Thechangesofclinicalsymptomsandsigns,uterinearterybloodflowandthebloodrheologywereobservedbeforeandaftertreatment.Result:Theimprovementofsyndromeofthetwotreatmentgroupsw

4、eresignificantlyabovethecontrolgroup.therewasnonotabledifferenceinthetotalcurativeeffectbetweentreatmentgroupⅠandthetreatmentgroupⅡ.Aftertreatment,uterinearterybloodflowandthebloodrheologywasdecreasedsignificantly(P﹤0.05).Conclusions:SGZTDecoctionisaneffectiverecipein

5、treatingPrimaryDysmenorrhea,theeffectcanbereducepelvicbloodflowresistance,amelioratingthebloodrheology.Longcourseofmedicationisbetterthanashortcourseoftreatmentmedication.KeywordsShuGanZhiTongDecoction;stagnationofqiandbloodstasis;PrimaryDysmenorrhea;clinicalcurative

6、effect目录引言...............................................................................................................................1临床研究............................................................................................................................

7、...2一、临床资料.......................................................................................................................2（一）病例来源...................................................................................................................2（二）诊断标准........

8、...........................................................................................................2（三）病例选择标准.......